Cargando…
Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia—A Meta-Regression Analysis
S100B has been linked to glial pathology in several psychiatric disorders. Previous studies found higher S100B serum levels in patients with schizophrenia compared to healthy controls, and a number of covariates influencing the size of this effect have been proposed in the literature. Here, we condu...
Autores principales: | Schümberg, Katharina, Polyakova, Maryna, Steiner, Johann, Schroeter, Matthias L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766293/ https://www.ncbi.nlm.nih.gov/pubmed/26941608 http://dx.doi.org/10.3389/fncel.2016.00046 |
Ejemplares similares
-
Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia
por: Milleit, Berko, et al.
Publicado: (2016) -
Increased Serum NSE and S100B Indicate Neuronal and Glial Alterations in Subjects Under 71 Years With Mild Neurocognitive Disorder/Mild Cognitive Impairment
por: Polyakova, Maryna, et al.
Publicado: (2022) -
S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance
por: Steiner, Johann, et al.
Publicado: (2010) -
First evidence for glial pathology in late life minor depression: S100B is increased in males with minor depression
por: Polyakova, Maryna, et al.
Publicado: (2015) -
Age- and Sex-Specific Standard Scores for the Reading the Mind in the Eyes Test
por: Kynast, Jana, et al.
Publicado: (2021)